Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Sarah L Kinch"'
Autor:
Lacy M Simons, Ramon Lorenzo-Redondo, Meg Gibson, Sarah L Kinch, Jacob P Vandervaart, Nina L Reiser, Mesut Eren, Elizabeth Lux, Elizabeth M McNally, Anat R Tambur, Douglas E Vaughan, Kelly E R Bachta, Alexis R Demonbreun, Karla J F Satchell, Chad J Achenbach, Egon A Ozer, Michael G Ison, Judd F Hultquist
Publikováno v:
Open forum infectious diseases. 9(3)
Background While several demographic and clinical correlates of coronavirus disease 2019 (COVID-19) outcome have been identified, their relationship to virological and immunological parameters remains poorly defined. Methods To address this, we perfo
Autor:
Elizabeth Lux, Judd F. Hultquist, Chad J. Achenbach, Michael G. Ison, Lacy M Simons, Anat R. Tambur, Karla J. F. Satchell, Elizabeth M. McNally, Egon A. Ozer, Jacob P Vandervaart, Alexis R. Demonbreun, Douglas E. Vaughan, Kelly E R Bachta, Mesut Eren, Meg Gibson, Nina L. Reiser, Ramon Lorenzo-Redondo, Sarah L Kinch
BackgroundWhile several demographic and clinical correlates of Coronavirus Disease 2019 (COVID-19) outcome have been identified, they remain imprecise tools for clinical management of disease. Furthermore, there are limited data on how these factors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a835ccb556bfa32f7c0a8852edea51e4
https://doi.org/10.1101/2021.07.02.21259665
https://doi.org/10.1101/2021.07.02.21259665
Publikováno v:
Drug Discovery Today. 19:1033-1039
The pharmaceutical industry is undergoing fundamental change and its future is unclear. We performed a meta-analysis by cataloging FDA-approved legacy drugs and new molecular entities (NMEs). Objective information regarding scientific, medical and co